StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SAG.L$580.00-0.85%
Fair $580.00+0.0%

SAG.L

Science Group plc

Industrials / Consulting ServicesLSE

$580.00

-5.00 (-0.85%)

Fairly Valued+0.0%Fair Value $580.00Fund rank 38/100 · Data gapFallback financials|
SA 63/B
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $18.5M · quality 78.7/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 77/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

63/100

B

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SAG.LLocal privado en este navegador · Science Group plc
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$238M

P/E

7.8x

↓

EV/EBITDA

519.4x

↑

ROE

32.2%

↑

Gross Margin

41.2%

↑

Debt/Equity

0.14

↓
52-Week Range$580
$460$612

TradingView lightweight chart

SAG.L price, volumen y niveles de valoración

Último $580.00Periodo +1350.0%
Fair value: $580.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+9.0%

FCF CAGR

+14.8%

FCF margin

20.6%

FCF / Net income

0.69x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $111.7M · net income $33.3M · FCF $23.0M

2022-FY → 2025-FY

Gross margin

41.2%-3.2% pts

Operating margin

15.1%+2.3% pts

Net margin

29.8%+17.6% pts

FCF margin

20.6%+3.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$111.7M$111.7M$110.7M$113.3M$86.3M
Net Income$33.3M$33.3M$12.0M$5.5M$10.6M
EBITDA$48.1M$48.1M$21.1M$15.1M$17.0M
EPS——0.260.120.23
Gross Margin41.2%41.2%40.8%40.8%44.4%
Operating Margin15.1%15.1%13.4%7.3%12.9%
Net Margin29.8%29.8%10.9%4.9%12.2%
Balance Sheet
Debt/Equity0.140.140.180.220.20
Current Ratio2.382.38———
Cash Flow
Free Cash Flow$23.0M$23.0M$18.5M$7.8M$15.2M
Returns
ROE32.2%32.2%14.3%7.0%13.5%
Valuation
P/E7.847.841742.313266.671747.79
EV/EBITDA519.44519.44991.471194.231088.29
P/B242.20242.20249.64231.06236.36
Growth & Yield
Revenue Growth0.9%0.9%-2.4%31.3%—
EPS Growth——116.7%-46.9%—
Dividend Yield1.7%1.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +26.4%

Total return

+26.4%

Start / end P/E

n/dx → n/dx

EPS bridge

0.26 → n/d

Residual

+24.7%

EPS growthn/d
Multiple reratingn/d
Dividend+1.7%
Residual / FX / buybacks / cross-term+24.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.